Simplified modeling strategies for surrogate validation with multivariate failure-time data
From MaRDI portal
Recommendations
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
- The evaluation of surrogate endpoints.
- Validation of surrogate markers in multiple randomized clinical trials with repeated measurements
- The Evaluation of Multiple Surrogate Endpoints
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
Cites work
- A version of the EM algorithm for proportional hazard model with random effects
- An introduction to copulas. Properties and applications
- Choice of units of analysis and modeling strategies in multilevel hierarchical models
- Comparison of different estimation procedures for proportional hazards model with random effects
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- scientific article; zbMATH DE number 3136275 (Why is no real title available?)
- scientific article; zbMATH DE number 3338262 (Why is no real title available?)
- Linear mixed models for longitudinal data
- On meta-analytic assessment of surrogate outcomes
- Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints
- Simplified hierarchical linear models for the evaluation of surrogate endpoints
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
Cited in
(2)
This page was built for publication: Simplified modeling strategies for surrogate validation with multivariate failure-time data
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2445595)